Caroline Lohrisch
0000-0003-0478-5987
Publication & Citation Trends
Publications
0 total
CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108
Cited by 2
Semantic Scholar
Abstracts reprinted from Journal of Clinical Oncology
Cited by 0
Semantic Scholar
Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer. OA
Cited by 225
Semantic Scholar
An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes.
Cited by 5
Semantic Scholar
Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades? OA
Cited by 151
Semantic Scholar
Standard medical treatment for early breast cancer.
Cited by 4
Semantic Scholar
Taxanes in the adjuvant treatment of breast cancer: why not yet? OA
Cited by 36
Semantic Scholar
Breast cancer: new aspects of adjuvant hormonal therapy. OA
Cited by 7
Semantic Scholar
Research Topics
Breast Cancer Treatment Studies
(84)
Cancer Treatment and Pharmacology
(42)
HER2/EGFR in Cancer Research
(36)
Advanced Breast Cancer Therapies
(31)
Breast Lesions and Carcinomas
(21)
Affiliations
European Organisation for Research and Treatment of Cancer
BC Cancer Agency
University of British Columbia
Provincial Health Services Authority
Simon Fraser University